ZNF518A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.141800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.605400E-01
Normal-vs-Stage2
4.977000E-01
Normal-vs-Stage3
1.917990E-01
Normal-vs-Stage4
9.996000E-01
Stage1-vs-Stage2
3.786400E-01
Stage1-vs-Stage3
3.287800E-02
Stage1-vs-Stage4
9.539200E-01
Stage2-vs-Stage3
1.503180E-01
Stage2-vs-Stage4
4.335600E-01
Stage3-vs-Stage4
1.330350E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.286800E-01
Normal-vs-AfricanAmerican
8.364800E-01
Normal-vs-Asian
2.103600E-01
Caucasian-vs-AfricanAmerican
7.054800E-01
Caucasian-vs-Asian
2.611200E-01
AfricanAmerican-vs-Asian
3.272000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.010600E-01
Normal-vs-Female
4.218600E-01
Male-vs-Female
3.905000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.943400E-01
Normal-vs-Age(41-60Yrs)
4.688200E-01
Normal-vs-Age(61-80Yrs)
5.556800E-01
Normal-vs-Age(81-100Yrs)
5.309000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.884400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.973600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.748800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.747800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.207600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.417000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.899600E-01
Normal-vs-Daily Drinker
7.533400E-01
Normal-vs-Weekly Drinker
7.482600E-01
Normal-vs-Occasional Drinker
4.842400E-01
Normal-vs-Social Drinker
5.958200E-01
Non Drinker-vs-Daily Drinker
4.008600E-01
Non Drinker-vs-Weekly Drinker
6.503200E-01
Non Drinker-vs-Occasional Drinker
6.409200E-01
Non Drinker-vs-Social Drinker
5.830400E-01
Daily Drinker-vs-Weekly Drinker
9.000600E-01
Daily Drinker-vs-Occasional Drinker
6.932400E-01
Daily Drinker-vs-Social Drinker
8.052200E-01
Weekly Drinker-vs-Occasional Drinker
8.628000E-01
Weekly Drinker-vs-Social Drinker
9.372200E-01
Occasional Drinker-vs-Social Drinker
8.938200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.799700E-02
Normal-vs-Grade 2
1.489950E-02
Normal-vs-Grade 3
9.522500E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.885200E-01
Grade 1-vs-Grade 3
2.272800E-01
Grade 1-vs-Grade 4
3.799700E-02
Grade 2-vs-Grade 3
5.825200E-01
Grade 2-vs-Grade 4
1.489950E-02
Grade 3-vs-Grade 4
9.522500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.453600E-01
Normal-vs-NonDiabetic
5.475600E-01
Diabetic-vs-NonDiabetic
2.424800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.212400E-01
Normal-vs-NoPancreatitis
4.534800E-01
Pancreatitis-vs-NoPancreatitis
5.317400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.135400E-01
Normal-vs-N1
5.068200E-01
N0-vs-N1
7.518600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.031600E-01
Normal-vs-TP53-NonMutant
8.559800E-01
TP53-Mutant-vs-TP53-NonMutant
7.841000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
